Business as usual. Revenue $31m in Q1 and Q2. Staff costs just under $5m in each quarter but Merchant payments up 9% on Q1 at $30.5m.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025